- Home
- FWRG vs AORT Comparison
FWRG vs AORT Comparison
Compare FWRG & AORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FWRG
- AORT
- Stock Information
- Founded
- FWRG 1983
- AORT 1984
- Country
- FWRG United States
- AORT United States
- Employees
- FWRG N/A
- AORT N/A
- Industry
- FWRG Restaurants
- AORT Medical/Dental Instruments
- Sector
- FWRG Consumer Discretionary
- AORT Health Care
- Exchange
- FWRG Nasdaq
- AORT Nasdaq
- Market Cap
- FWRG 970.4M
- AORT 1.4B
- IPO Year
- FWRG 2021
- AORT 1993
- Fundamental
- Price
- FWRG $17.51
- AORT $31.66
- Analyst Decision
- FWRG Strong Buy
- AORT Strong Buy
- Analyst Count
- FWRG 10
- AORT 5
- Target Price
- FWRG $22.20
- AORT $32.40
- AVG Volume (30 Days)
- FWRG 815.6K
- AORT 349.3K
- Earning Date
- FWRG 08-05-2025
- AORT 08-07-2025
- Dividend Yield
- FWRG N/A
- AORT N/A
- EPS Growth
- FWRG N/A
- AORT N/A
- EPS
- FWRG 0.17
- AORT N/A
- Revenue
- FWRG $1,055,701,000.00
- AORT $390,084,000.00
- Revenue This Year
- FWRG $21.37
- AORT $12.18
- Revenue Next Year
- FWRG $15.98
- AORT $10.39
- P/E Ratio
- FWRG $102.34
- AORT N/A
- Revenue Growth
- FWRG 14.43
- AORT 5.94
- 52 Week Low
- FWRG $12.90
- AORT $21.97
- 52 Week High
- FWRG $22.71
- AORT $32.94
- Technical
- Relative Strength Index (RSI)
- FWRG 58.47
- AORT 62.03
- Support Level
- FWRG $17.17
- AORT $30.06
- Resistance Level
- FWRG $18.46
- AORT $32.94
- Average True Range (ATR)
- FWRG 0.81
- AORT 0.79
- MACD
- FWRG 0.20
- AORT 0.06
- Stochastic Oscillator
- FWRG 73.86
- AORT 61.37
About FWRG First Watch Restaurant Group Inc.
First Watch Restaurant Group Inc is a daytime restaurant concept serving made-to-order breakfast, brunch, and lunch using fresh ingredients. It generates revenues from Restaurant sales and Franchise revenues.
About AORT Artivion Inc.
Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others. The company's has two reportable segments: Medical Devices and Preservation Services. The Medical Devices segment includes revenues from sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. The Preservation Services segment includes services revenues from the preservation of cardiac and vascular implantable human tissues. Company operates in North America, EMEA. LATAM, APAC. Maximum revenue is from North America.